Postdoctoral program
V. Economic competitiveness and innovative technologies
Institute of Chemistry
The project is dedicated to obtaining enantiomerically pure compounds with biological properties, which provide greater activity and fewer side effects compared to a racemic or diastereomeric mixture. Target compounds will have a polycyclic structure, will be obtained on the basis of the modification of carbonyl substances and will have applicability in pharmacy and agriculture. The project will be carried out in 4 main stages and will include the synthesis and characterization of oxindole-based compounds, 2-hydroxyjuglone-based compounds, steroid-based compounds, as well as the formation and writing of the doctoral dissertation. In addition, in cooperation with the Rega Medical Research Institute (Leuven, Belgium), Aristotle University (Thessaloniki, Greece), Testimitsanu University of Medicine and Pharmacy (Moldova), Comrat State University (Moldova), the biological properties of the obtained compounds will be investigated. The project will be focused on conductive an exhaustive search of new and more effective drug candidates with the least cytotoxicity. To achieve this goal, two synthetic strategies will be applied. First, a library of analogues of substances similar to known natural and synthetic products will be created. Isatin, naphthoquinone and steroids will be used as the main elements to introduce molecular diversity. Secondly, a new library of mimetic derivatives will be obtained by introducing a new class of kernels for obtaining polycycles. Both strategies will use advanced synthetic approaches to create new bioactive chemical topologies that will bring economic and social benefits. At the final stage of the announced project, the conditions for obtaining the most promising compounds will be optimized and laboratory regulations will be developed to expand production.